On the other hand, miR-133b also directly targets enzymes involved in fatty acid biosynthesis, such as Acaca or Acsl4, whose inhibition may play a role in the decreased hepatic steatosis in EV mice [66,67]. Here, ACACA is linked to fatty liver disease.